Table 2 Patient characteristics, subjects with cancer (N = 170)
From: Navigating veterans with an abnormal prostate cancer screening test: a quasi-experimental study
|  | Navigated (N = 84) | Control (N = 86) | p-value |
|---|---|---|---|
| Â | N(%) | N(%) | Â |
Age | Â | Â | 0.17 |
< 65Â years old | 47 (56) | 39 (45) | Â |
≥ 65 years old | 37 (44) | 47 (55) |  |
Range | 50-79 | 43-92 | Â |
Race/ethnicity | Â | Â | 0.011 |
African American | 53 (63) | 64 (74) | Â |
White | 23 (27) | 13 (15) | Â |
Other | 7 (8) | 2 (2) | Â |
Not reported | 1 (1) | 7 (8) | Â |
Gleason score | Â | Â | 0.008 |
≤ 3 + 3 | 45 (54) | 28 (33) |  |
> 3 + 3 | 39 (46) | 58 (67) |  |
Consultation beyond Urology a | Â | Â | 0.36 |
Yes | 35 (42) | 42 (49) | Â |
No | 49 (58) | 44 (51) | Â |
Primary Therapy | Â | Â | 0.45 |
Prostatectomy | 26 (30) | 24 (28) | Â |
External Radiation Therapy | 14 (17) | 13 (15) | Â |
Hormone Therapy | 17 (20) | 28 (33) | Â |
Watchful Waiting | 15 (18) | 14 (28) | Â |
Interstitial Radiation Therapy | 2 (2) | 0 (0) | Â |
Cryotherapy | 1 (1) | 0 (0) | Â |
Treatment not initiated | 9 (11) | 7 (8) | Â |